How to use Technologies searched

A search for a company looking for a cancer, preclinical stage, synthetic opportunity would use the selection "Biomedicine, Diagnostics" in 'Sector', 'Cancerous, neoplasmatic' in 'Disease Category', 'Drugs, Small Molecule' in 'Technology' and 'Preclinical' in 'Development Stage'.

Selection of 'Enabling Technology, Platform technology' in 'Sector' will identify all kinds of searches for technologies that can be used in more areas of life sciences than pharmaceuticals only.

Each search profile gives the name or a short description of the company behind the search, and a link allowing to contact your potential licensee.

Registered users can create non-public notifications profiles which will inform them about new Technologies Searched entries fitting their expertise as specified. In addition these profiles allow them to filter the available information more comfortably.

Name

Auxilium is seeking opportunities in urology and sexual health

Organization name

Auxilium Pharmaceuticals

Profile

Auxilium Pharmaceuticals was founded in 1999 to develop and market pharmaceutical products that focus on urology and sexual health. While they remain dedicated to this founding principle, Auxilium´s mission has expanded to include the development and marketing of novel treatment options for many of society´s unmet medical needs.

To support this mission of providing innovative solutions that promote healthy living, Auxilium is:

  • providing healthcare specialists with quality products and practice support
  • building on its development capability to deliver high-quality products for a range of unmet health needs
  • pursuing licensing opportunities for additional products that complement its mission and development portfolio
  • exploring business development and partnership opportunities

Auxilium´s core competency lies in the development and commercialization of therapeutics that address unmet medical needs. Given their corporate strategy of focusing resources outside of discovery activities, they rely on their business development group to serve this crucial function of sourcing innovation. In fact, Auxilium´s product and pipeline candidates have all been derived from licensing partnerships. Furthermore, collaborations enable Auxilium to maximize the value of its products once approved.

Auxilium seeks to in-partner products that treat serious problems that affect men and women as they age. Auxilium will consider various partnership arrangements such as: licensing, acquisition, and promotion. The company prefers marketed products or late-stage therapeutic candidates, but will consider earlier stage opportunities for differentiated molecules/products.

Indications of interest include:

  • Benign prostatic hyperplasia
  • Bladder cancer
  • Erectile dysfunction
  • Female sexual dysfunction
  • Hypogonadism (TRT)
  • Interstitial cystitis
  • Male contraception
  • Pain products
  • Penile cancer
  • Peyronie´s disease
  • Premature ejaculation
  • Prostate cancer
  • Urinary antispasmodics
  • Urinary incontinence / overactive bladder
  • Urinary tract infections
  • Other urologic or genitourinary abnormalities
  • Endocrine-related disease states

To view the contact information, attachments and url of this profile you have to login into your account or register a new account: Login Register

Your feedback

Please click here to log in to view the complete profile.

 
 

latest entries